OcuMension

📍 上海市, China🗓 Founded 2018👥 25 employees💰 Last funded Apr 2017
Pharmaceutical Manufacturing
LinkedIn
Ocumension Therapeutics established in May 2018, is a company which focuses on the development of ophthalmic medications. The management team of the company possesses extensive experience in R&D, clinical trials, marketing and promotion, and commercial operation. With our ocular disease focus, the company strives to continuously provide important needed therapies to Chinese patients using innovative products derived from both inhouse R&D and strategic alliance with global partners.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in OcuMension?
OcuMension has 1 investors on record on gritt.io, including 1 early-stage backers.
When did OcuMension last raise funding?
The most recent investment in OcuMension recorded on gritt.io was in April 2017.
When was OcuMension founded?
OcuMension was founded in 2018.
What industry is OcuMension in?
OcuMension operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is OcuMension based?
OcuMension is headquartered in 上海市, China.